Wondering how to use Biolinerx in a sentence? Below are 4 example sentences from authentic English texts. .
Biolinerx in a sentence
Using Biolinerx
- In the example corpus, biolinerx often appears in combinations such as: biolinerx ltd.
Context around Biolinerx
- Average sentence length in these examples: 21 words
- Position in the sentence: 1 start, 2 middle, 1 end
- Sentence types: 4 statements, 0 questions, 0 exclamations
Corpus analysis for Biolinerx
- In this selection, "biolinerx" usually appears in the middle of the sentence. The average example has 21 words, and this corpus slice is mostly made up of statements.
- Around the word, cover, upgraded and ltd stand out and add context to how "biolinerx" is used.
- Recognizable usage signals include predict that biolinerx ltd s and research upgraded biolinerx ltd s. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "biolinerx" sits close to words such as aaas, aacc and aacs, which helps place it inside the broader word index.
Example types with biolinerx
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
As a group, analysts predict that BIOLINERX LTD/S will post -0.22 EPS for the current fiscal year. (19 words)
Deutsche Bank AG purchased a new position in shares of BIOLINERX LTD/S in the fourth quarter worth $26,000. (20 words)
Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that cover BIOLINERX LTD/S. (22 words)
Zacks Investment Research upgraded BIOLINERX LTD/S from a “sell” rating to a “hold” rating in a research note on Wednesday, November 7th. (23 words)
Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that cover BIOLINERX LTD/S. (22 words)
Deutsche Bank AG purchased a new position in shares of BIOLINERX LTD/S in the fourth quarter worth $26,000. (20 words)
Example sentences (4)
Deutsche Bank AG purchased a new position in shares of BIOLINERX LTD/S in the fourth quarter worth $26,000.
As a group, analysts predict that BIOLINERX LTD/S will post -0.22 EPS for the current fiscal year.
Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that cover BIOLINERX LTD/S.
Zacks Investment Research upgraded BIOLINERX LTD/S from a “sell” rating to a “hold” rating in a research note on Wednesday, November 7th.
Common combinations with biolinerx
These word pairs occur most frequently in English texts: